Study Overview:
Volume Reduction with
MIST Therapy plus SOC in non-progressing wounds within an average of 5.5 weeks as compared to 37.3% Wound Volume
Reduction within an average of 9.8 weeks with SOC alone. (P < 0.0001)
Accelerating the Rate of Healing

MIST Therapy
® uses low-frequency ultrasound to stimulate cells at and below the wound surface to activate healing. A painless procedure, it is the only noncontact, low-frequency ultrasound device for healing cleared by the FDA. 
94.9% Patients Like Yours?
This study examined patients with multifactorial etiologies like Ben. He is 72 years old, has Type 2 diabetes and is a former smoker. He had a chronic diabetic foot ulcer (Wagner grade two) that he had endured for more than 3 months.
The study found that wounds like Ben's healed considerably faster when treated with MIST Therapy plus standard of care.
Physician Observations
"Our experience using MIST Therapy was very positive. MIST seems to be an effective modality for the treatment of wounds. This modality has demonstrated a reduction in healing time and has brought many recalcitrant wounds to closure after the standard of care regimen had failed to do so." Painless, Accelerated Healing with MIST Therapy ® MIST Therapy is an innovative, noncontact approach to wound healing. The system creates low-frequency ultrasound waves that produce and propel a gentle mist of sterile saline into the wound bed. The saline mist improves the transfer of ultrasound from the device without contact or pain to the patient.
MIST Therapy promotes painless wound healing through:
• Active cell stimulation MIST Therapy System FDA Clearance. 510 (k) Clearance June 2005. "The MIST Therapy System produces a low-frequency ultrasound-generated mist used to promote wound healing through wound cleansing and maintenance debridement by the removal of yellow slough, fibrin, tissue, exudates and bacteria."
